ISIS Pharmaceuticals (ISIS) Hit Following Two-Notch Analyst Downgrade
Tweet Send to a FriendGet Alerts ISIS Hot Sheet
Up)
Trade ISIS Now!
ISIS Pharmaceuticals (Nasdaq: ISIS) is getting hit Thursday, following a two-notch downgrade at Jefferies, issued earlier.
Shares are over 9 percent lower on the session with volume over 500K shares so far.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Shares are over 9 percent lower on the session with volume over 500K shares so far.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Fannie Mae, Freddie Mac Surge as Seriously Delinquent Rate Falls Below 3%
- InterOil (IOC) Gives Up Gains
- UPDATE: Intuitive Surgical (ISRG) Jury Reaches Positive Verdict in Robot Case; Shares Rise
Create E-mail Alert Related Categories
Insiders' Blog, Momentum MoversRelated Entities
Jefferies & Co
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
